NAVEEN PEMMARAJU to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications NAVEEN PEMMARAJU has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.166
-
Evaluating tagraxofusp for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Expert Opin Pharmacother. 2022 Mar; 23(4):431-438.
Score: 0.166